MED
Medifast, Inc.$12.09-0.17 (-1.39%)Prev Close$12.26·MCap$117.3M·P/E—·Vol129.3K·Yield—
▲
Buys (12M)
6
$1.73M
▼
Sells (12M)
1
$226.3K
◆
Net Activity
Net Buyer
$1.51M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Medifast, Inc. (MED) has been dominated by buying, with 6 insider purchases totaling $1.73M and 1 insider sale totaling $226.3K. The most recent insider transaction was by Kiai Parsa (director), who purchased $68.0K worth of shares on Oct 30, 2026. Medifast, Inc. operates in the Consumer Cyclical sector, within the Personal Products & Services industry, with a market cap of $117.3M.
MED Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Kiai Parsa | director | Buy | 5,557 | $12.24 | $68.0K | 712,891 |
| Sep 30, 2026 | Chard Daniel R | director | Sell | 19,089 | $11.85 | $226.3K | 140,153 |
| Aug 28, 2026 | Kiai Parsa | director | Buy | 43,150 | $12.26 | $529.2K | 707,492 |
| Aug 26, 2026 | Kiai Parsa | director | Buy | 4,329 | $12.00 | $51.9K | 665,517 |
| Aug 21, 2026 | Kiai Parsa | director | Buy | 72,487 | $11.63 | $842.7K0.7% OS | 661,306 |
| May 12, 2026 | SCHLACKMAN SCOTT | director | Buy | 5,000 | $12.59 | $63.0K | 30,549 |
| Mar 27, 2026 | Chard Daniel R | director, officer: Chairman & CEO | Buy | 17,678 | $10.11 | $178.7K | 17,678 |
| Jun 13, 2025 | Chard Daniel R | Chairman & CEO | Buy | 381 | $13.13 | $5.0K | 0 |
| Mar 13, 2025 | Chard Daniel R | Chairman & CEO | Sell | 7,809 | $13.99 | $109.3K | 0 |
| Mar 13, 2025 | MacKenzie Jonathan Barrett | VP, Finance & CAO | Sell | 439 | $13.99 | $6.1K | 0 |
| Mar 13, 2025 | Maloney James P. | Chief Financial Officer | Sell | 1,396 | $14.03 | $19.6K | 0 |
| Mar 12, 2024 | SCHLACKMAN SCOTT | Director | Sell | 4,053 | $39.44 | $159.9K | 10,538-28% |
| Nov 9, 2023 | BROWN JEFFREY J | Director | Buy | 154 | $69.92 | $10.8K | 5,784 |
| Nov 9, 2023 | Hoer Michael A. | Director | Buy | 49 | $68.89 | $3.4K | 8,375 |
| Nov 9, 2023 | SCHLACKMAN SCOTT | Director | Buy | 52 | $68.89 | $3.6K | 10,538 |
| Nov 9, 2023 | Thomas Andrea B | Director | Buy | 50 | $68.89 | $3.4K | 6,253 |
| Oct 30, 2023 | HALLQUIST CONSTANCE J. | Sell | 5,613 | $73.87 | $414.6K | 2,152-72% | |
| Aug 16, 2023 | BROWN JEFFREY J | Director | Sell | 38,316 | $91.14 | $3.49M | 23,163-62% |
| Aug 10, 2023 | BROWN JEFFREY J | Director | Buy | 732 | $99.39 | $72.8K | 38,317 |
| Aug 10, 2023 | Hoer Michael A. | Director | Buy | 37 | $89.42 | $3.3K | 8,326 |
| Aug 10, 2023 | SCHLACKMAN SCOTT | Director | Buy | 39 | $89.42 | $3.5K | 10,485 |
| Aug 10, 2023 | Thomas Andrea B | Director | Buy | 38 | $89.42 | $3.4K | 6,203 |
| May 11, 2023 | BROWN JEFFREY J | Director | Buy | 768 | $89.70 | $68.9K | 37,695 |
| May 11, 2023 | HALLQUIST CONSTANCE J. | Director | Buy | 13 | $87.50 | $1.1K | 7,591 |
| May 11, 2023 | Hoer Michael A. | Director | Buy | 12 | $87.50 | $1.1K | 5,170 |
| May 11, 2023 | SCHLACKMAN SCOTT | Director | Buy | 13 | $87.50 | $1.1K | 7,293 |
| May 11, 2023 | Thomas Andrea B | Director | Buy | 12 | $87.50 | $1.1K | 3,047 |
| Mar 14, 2023 | SCHLACKMAN SCOTT | Director | Sell | 2,200 | $108.68 | $239.1K | 7,280 |
| Feb 9, 2023 | BROWN JEFFREY J | Director | Buy | 581 | $116.09 | $67.4K | 37,014 |
| Feb 9, 2023 | HALLQUIST CONSTANCE J. | Director | Buy | 9 | $114.97 | $1.0K | 7,578 |
| Feb 9, 2023 | Hoer Michael A. | Director | Buy | 9 | $114.97 | $1.0K | 5,157 |
| Feb 9, 2023 | SCHLACKMAN SCOTT | Director | Buy | 9 | $114.97 | $1.0K | 7,280 |
| Feb 9, 2023 | Thomas Andrea B | Director | Buy | 9 | $114.97 | $1.0K | 3,034 |
| Nov 10, 2022 | BROWN JEFFREY J | Director | Buy | 571 | $105.10 | $60.0K | 36,499 |
| Nov 10, 2022 | HALLQUIST CONSTANCE J. | Director | Buy | 10 | $106.93 | $1.1K | 7,893 |
| Nov 10, 2022 | Hoer Michael A. | Director | Buy | 10 | $106.93 | $1.1K | 5,148 |
| Nov 10, 2022 | SCHLACKMAN SCOTT | Director | Buy | 10 | $106.93 | $1.1K | 7,270 |
| Nov 10, 2022 | Thomas Andrea B | Director | Buy | 10 | $106.93 | $1.1K | 3,024 |
| Aug 11, 2022 | BROWN JEFFREY J | Director | Buy | 3,940 | $126.54 | $498.5K | 3,940 |
| Aug 10, 2022 | BROWN JEFFREY J | Director | Buy | 399 | $146.01 | $58.3K | 35,938 |
| May 11, 2022 | BROWN JEFFREY J | Director | Buy | 315 | $183.25 | $57.7K | 35,539 |
| May 11, 2022 | Chard Daniel R | Chairman & CEO | Buy | 431 | $183.25 | $79.0K | 108,598 |
| Apr 21, 2022 | BROWN JEFFREY J | Director | Buy | 266 | $186.40 | $49.6K | 35,223 |
| Apr 21, 2022 | Chard Daniel R | Chairman & CEO | Buy | 690 | $186.40 | $128.6K | 103,839 |
| Mar 14, 2022 | Thomas Andrea B | Director | Sell | 1,150 | $174.31 | $200.5K | 1,640-41% |
| Nov 10, 2021 | BROWN JEFFREY J | Director | Buy | 4,199 | $231.89 | $973.7K | 34,957 |
| Aug 24, 2021 | BYRNES KEVIN G | Director | Sell | 673 | $221.99 | $149.4K | 8,154 |
| Aug 10, 2021 | BROWN JEFFREY J | Director | Buy | 142 | $286.16 | $40.6K | 30,757 |
| Jul 7, 2021 | HALLQUIST CONSTANCE J. | Sell | 542 | $285.09 | $154.5K | 6,442 | |
| Jun 21, 2021 | Chard Daniel R | Chairman & CEO | Sell | 6,365 | $263.55 | $1.68M | 112,091 |
Showing 1–50 of 55
1 / 2
MED Insider Buying Activity
The following table shows recent insider purchases of Medifast, Inc. (MED) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Kiai Parsa | director | Buy | 5,557 | $12.24 | $68.0K | 712,891 |
| Aug 28, 2026 | Kiai Parsa | director | Buy | 43,150 | $12.26 | $529.2K | 707,492 |
| Aug 26, 2026 | Kiai Parsa | director | Buy | 4,329 | $12.00 | $51.9K | 665,517 |
| Aug 21, 2026 | Kiai Parsa | director | Buy | 72,487 | $11.63 | $842.7K0.7% OS | 661,306 |
| May 12, 2026 | SCHLACKMAN SCOTT | director | Buy | 5,000 | $12.59 | $63.0K | 30,549 |
| Mar 27, 2026 | Chard Daniel R | director, officer: Chairman & CEO | Buy | 17,678 | $10.11 | $178.7K | 17,678 |
| Jun 13, 2025 | Chard Daniel R | Chairman & CEO | Buy | 381 | $13.13 | $5.0K | 0 |
| Nov 9, 2023 | BROWN JEFFREY J | Director | Buy | 154 | $69.92 | $10.8K | 5,784 |
| Nov 9, 2023 | Hoer Michael A. | Director | Buy | 49 | $68.89 | $3.4K | 8,375 |
| Nov 9, 2023 | SCHLACKMAN SCOTT | Director | Buy | 52 | $68.89 | $3.6K | 10,538 |
| Nov 9, 2023 | Thomas Andrea B | Director | Buy | 50 | $68.89 | $3.4K | 6,253 |
| Aug 10, 2023 | BROWN JEFFREY J | Director | Buy | 732 | $99.39 | $72.8K | 38,317 |
| Aug 10, 2023 | Hoer Michael A. | Director | Buy | 37 | $89.42 | $3.3K | 8,326 |
| Aug 10, 2023 | SCHLACKMAN SCOTT | Director | Buy | 39 | $89.42 | $3.5K | 10,485 |
| Aug 10, 2023 | Thomas Andrea B | Director | Buy | 38 | $89.42 | $3.4K | 6,203 |
| May 11, 2023 | BROWN JEFFREY J | Director | Buy | 768 | $89.70 | $68.9K | 37,695 |
| May 11, 2023 | HALLQUIST CONSTANCE J. | Director | Buy | 13 | $87.50 | $1.1K | 7,591 |
| May 11, 2023 | Hoer Michael A. | Director | Buy | 12 | $87.50 | $1.1K | 5,170 |
| May 11, 2023 | SCHLACKMAN SCOTT | Director | Buy | 13 | $87.50 | $1.1K | 7,293 |
| May 11, 2023 | Thomas Andrea B | Director | Buy | 12 | $87.50 | $1.1K | 3,047 |
| Feb 9, 2023 | BROWN JEFFREY J | Director | Buy | 581 | $116.09 | $67.4K | 37,014 |
| Feb 9, 2023 | HALLQUIST CONSTANCE J. | Director | Buy | 9 | $114.97 | $1.0K | 7,578 |
| Feb 9, 2023 | Hoer Michael A. | Director | Buy | 9 | $114.97 | $1.0K | 5,157 |
| Feb 9, 2023 | SCHLACKMAN SCOTT | Director | Buy | 9 | $114.97 | $1.0K | 7,280 |
| Feb 9, 2023 | Thomas Andrea B | Director | Buy | 9 | $114.97 | $1.0K | 3,034 |
| Nov 10, 2022 | BROWN JEFFREY J | Director | Buy | 571 | $105.10 | $60.0K | 36,499 |
| Nov 10, 2022 | HALLQUIST CONSTANCE J. | Director | Buy | 10 | $106.93 | $1.1K | 7,893 |
| Nov 10, 2022 | Hoer Michael A. | Director | Buy | 10 | $106.93 | $1.1K | 5,148 |
| Nov 10, 2022 | SCHLACKMAN SCOTT | Director | Buy | 10 | $106.93 | $1.1K | 7,270 |
| Nov 10, 2022 | Thomas Andrea B | Director | Buy | 10 | $106.93 | $1.1K | 3,024 |
| Aug 11, 2022 | BROWN JEFFREY J | Director | Buy | 3,940 | $126.54 | $498.5K | 3,940 |
| Aug 10, 2022 | BROWN JEFFREY J | Director | Buy | 399 | $146.01 | $58.3K | 35,938 |
| May 11, 2022 | BROWN JEFFREY J | Director | Buy | 315 | $183.25 | $57.7K | 35,539 |
| May 11, 2022 | Chard Daniel R | Chairman & CEO | Buy | 431 | $183.25 | $79.0K | 108,598 |
| Apr 21, 2022 | BROWN JEFFREY J | Director | Buy | 266 | $186.40 | $49.6K | 35,223 |
| Apr 21, 2022 | Chard Daniel R | Chairman & CEO | Buy | 690 | $186.40 | $128.6K | 103,839 |
| Nov 10, 2021 | BROWN JEFFREY J | Director | Buy | 4,199 | $231.89 | $973.7K | 34,957 |
| Aug 10, 2021 | BROWN JEFFREY J | Director | Buy | 142 | $286.16 | $40.6K | 30,757 |
MED Insider Selling Activity
The following table shows recent insider sales of Medifast, Inc. (MED) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Chard Daniel R | director | Sell | 19,089 | $11.85 | $226.3K | 140,153 |
| Mar 13, 2025 | Chard Daniel R | Chairman & CEO | Sell | 7,809 | $13.99 | $109.3K | 0 |
| Mar 13, 2025 | MacKenzie Jonathan Barrett | VP, Finance & CAO | Sell | 439 | $13.99 | $6.1K | 0 |
| Mar 13, 2025 | Maloney James P. | Chief Financial Officer | Sell | 1,396 | $14.03 | $19.6K | 0 |
| Mar 12, 2024 | SCHLACKMAN SCOTT | Director | Sell | 4,053 | $39.44 | $159.9K | 10,538-28% |
| Oct 30, 2023 | HALLQUIST CONSTANCE J. | Sell | 5,613 | $73.87 | $414.6K | 2,152-72% | |
| Aug 16, 2023 | BROWN JEFFREY J | Director | Sell | 38,316 | $91.14 | $3.49M | 23,163-62% |
| Mar 14, 2023 | SCHLACKMAN SCOTT | Director | Sell | 2,200 | $108.68 | $239.1K | 7,280 |
| Mar 14, 2022 | Thomas Andrea B | Director | Sell | 1,150 | $174.31 | $200.5K | 1,640-41% |
| Aug 24, 2021 | BYRNES KEVIN G | Director | Sell | 673 | $221.99 | $149.4K | 8,154 |
| Jul 7, 2021 | HALLQUIST CONSTANCE J. | Sell | 542 | $285.09 | $154.5K | 6,442 | |
| Jun 21, 2021 | Chard Daniel R | Chairman & CEO | Sell | 6,365 | $263.55 | $1.68M | 112,091 |